Monopar Therapeutics Inc

NASDAQ:MNPR   3:59:29 PM EDT
2.09
-0.16 (-7.11%)
Earnings Announcements

Monopar Therapeutics Reports First Quarter 2022 Financial Results

Published: 05/12/2022 12:40 GMT
Monopar Therapeutics Inc (MNPR) - Monopar Therapeutics Reports First Quarter 2022 Financial Results and Recent Program Developments.
Qtrly Net Loss per Share$0.19.
Q1 Earnings per Share View $-0.22 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.22

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.21

More details on our Analysts Page.